Phrenic Nerve Infiltration in Fibromyalgia
Fibromyalgia
About this trial
This is an interventional treatment trial for Fibromyalgia focused on measuring phrenic nerve, anesthesia, local, anesthetics, Pain, Bupivacaine
Eligibility Criteria
Inclusion Criteria: Women Over 18 and under 64 years old Diagnosis of Fibromyalgia Any peridiaphragmatic visceral disorder diagnosed by the respective specialist. That the subject agrees to participate in the project by signing the informed consent. Exclusion Criteria: Other rheumatic diseases. Degenerative neurological disease. Major psychiatric disorder Cognitive deterioration Non-cooperative subject Any medical condition affecting sensory evaluation Contraindication to infiltration of the phrenic nerve.
Sites / Locations
- Nacho Navarro FisioterapiaRecruiting
- Asociación de Fibromialgia de LebrijaRecruiting
- Asociación de Fibromialgia de SevillaRecruiting
- Hospitales Universitarios Virgen del Rocío y MacarenaRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Placebo Comparator
Phrenic nerve anesthetics infiltration
Physiological serum infiltration
The experimental intervention will consist of ultrasound-guided anesthetic blockade of the phrenic nerve at the laterocervical supraclavicular level with 1 ml of lidocaine without vasoconstrictor 2% to infiltrate the skin and 3ml of bupivacaine without vasoconstrictor 0.25% for neural blockade, making the local anesthetic surround the nerve between the anterior scalene muscle and the sternocleidomastoid muscle.
The placebo intervention will be similar in relation to 2% lidocaine without vasoconstrictor for the skin, but an ultrasound-guided puncture will be performed at the level of the subcutaneous cellular tissue by injecting 3 ml of physiological saline.